The future of liquid biopsies: an interview with Bob Li

Written by Jade Parker, Senior Editor

We recently had the opportunity to interview Bob Li, MD (Memorial Sloan Kettering Cancer Center, MSK, NY, USA) about his research into liquid biopsies. He provides an important insight into the potential of liquid biopsies and their future as a clinical tool, as well as highlighting the important work that still needs to be done to ensure its success.  Li also discusses his latest research; from how ultra-deep NGS of plasma circulating cell-free DNA (cfDNA) is being used in patients with advanced lung cancers; to the outcome of the basket trial that used ado-trastuzumab emtansine to treat salivary gland cancers....

To view this content, please register now for access

It's completely free